By Brittany Trang and Jason Mast
Sept. 19, 2024
Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find customers.
The biotech this week announced a new artificial intelligence model for use in biological research, as well as a data service academic researchers and companies can use to develop their own models. The announcement comes as a growing number of biotechs, big tech companies, and academics apply neural networks and machine learning to biology, promising that the same basic technology that powers ChatGPT can also help design new therapies and speed the pace of fundamental research.
advertisement
Ginkgo executives say the new efforts provide an opportunity where it can clearly compete. But experts and analysts aren’t so sure. Ginkgo faces competition for both of the new services it’s now offering and it’s not clear how much — if any — advantage the struggling company offers.
STAT+ Exclusive Story
Already have an account? Log in
Already have an account? Log in
Monthly
$39
Totals $468 per year
$39/month Get StartedTotals $468 per year
Starter
$20
for 3 months, then $399/year
$20 for 3 months Get StartedThen $399/year
Annual
$399
Save 15%
$399/year Get StartedSave 15%
11+ Users
Custom
Savings start at 25%!
Request A Quote Request A QuoteSavings start at 25%!
2-10 Users
$300
Annually per user
$300/year Get Started$300 Annually per user
View All PlansTo read the rest of this story subscribe to STAT+.
Subscribe Log In Artificial intelligence, STAT+ Submit a correction requestReprintsBrittany Trang
Health Tech Reporter
Brittany Trang, Ph.D., is a health tech reporter at STAT. Follow her on Threads, Mastodon, and Bluesky.
Jason Mast
General Assignment Reporter
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients.
Your morning rundown of the science, politics, and money driving biotech today